Sunshine Biopharma Inc.
SBFM
Revenue
9.30M
▲1.76M▲23.37%
3 Months ChangeAssets
29.30M
▼-2.60M▼-8.14%
3 Months ChangeLiabilities
5.81M
▼-1.27M▼-17.91%
3 Months ChangeFree Cash Flow
-233.96k
▼-60.72k▼-35.05%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 8-K
ID: 0001683168-24-007323
2024-09-10
Form 8-K
ID: 0001683168-24-006281
2024-08-19
Form 8-K
ID: 0001683168-24-005903
2024-08-16
Form 10-Q
ID: 0001683168-24-005846
2024-08-12
Form 8-K
ID: 0001683168-24-005496
2024-07-02
Form 8-K
ID: 0001683168-24-004601
2024-07-01
Form 8-K
ID: 0001683168-24-004572
2024-06-11
Form 8-K
ID: 0001683168-24-004120
2024-06-07
Form 8-K
ID: 0001683168-24-004053
2024-05-22
Form 8-K
ID: 0001683168-24-003777